Skip to main content
. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613
BMI body mass index
CB1 cannabinoid receptor 1
CVD cardiovascular disease
DHA docosahexaenoic acid
DMB 3,3-dimethyl-1-butanol
eCB endocannabinoid
EPA eicosapentaenoic acid
FMT fecal microbial transplantation
FODMAP fermentable oligo-, di-, mono-saccharides and polyols
FOS fructo-oligosaccharide
GABA γ-aminobutyric acid
GI gastrointestinal
GOS galacto-oligosaccharide
GPCR G-protein coupled receptor
GPR109A niacin receptor 1
GPR41 free fatty acid receptor 3
HR hazard ratio
HDL high-density lipoprotein
IBD inflammatory bowel disease
IBS irritable bowel syndrome
IBS-C IBS with predominant constipation
IBS-D IBS with predominant diarrhea
IBS-M IBS with alternating bowel habits
KD ketogenic diet
LDL low-density lipoprotein
LPS lipopolysaccharide (endotoxin)
NAS non-caloric artificial sweetener
NCGS non-celiac gluten sensitivity
P probability value
PPAR-γ peroxisome proliferator-activated receptor gamma
PPI proton pump inhibitor
PUFA polyunsaturated fatty acid
R Pearson correlation coefficient
RYGB Roux-en-Y gastric bypass
SCD specific carbohydrate diet
SCFA short-chain fatty acid
sdLDL small dense low-density lipoprotein particle
SGLT1 sodium glucose cotransporter-1
SIBO small intestinal bacterial overgrowth
THC tetrahydrocannabinol
TMA trimethylamine
TMAO trimethylamine N-oxide
TNF tumor necrosis factor
T2D type 2 diabetes